newsfilter
← Latest News
Business Wire·

Small Pharma Obtains Final Order Approving Arrangement

Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) ("Small Pharma"), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions and Cybin Inc. (NYSE:CYBN) (NEO:CYBN) ("Cybin"),